Skip to main content
Retour
PRGO logo

Perrigo Company plc

Qualité des données : 100%
PRGO
NYSE Healthcare Drug Manufacturers - Specialty & Generic
9,69 €
▲ 0,05 € (0,52%)
Cap. Boursière : 1,33B
Fourchette du Jour
9,43 € 9,99 €
Fourchette 52 Semaines
9,23 € 28,44 €
Volume
2 496 293
Moyenne 50J / 200J
13,28 € / 19,16 €
Clôture Précédente
9,64 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (631 pairs)

Métrique Action Médiane du Secteur
P/E -0,9 0,2
P/B 0,5 3,0
ROE % -39,3 3,6
Net Margin % -33,5 3,8
Rev Growth 5Y % 0,7 9,7
D/E 1,4 0,2

Objectif de Cours des Analystes

Hold
21,50 € +121.9%
Low: 20,00 € High: 23,00 €
P/E Prévisionnel
4,25
BPA Prévisionnel
2,28 €
Croissance BPA (est.)
+0,0%
CA Est.
4,13B

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2030 2,92 €
2,90 € – 2,95 €
4,26B 1
FY2029 2,82 €
2,80 € – 2,85 €
4,21B 1
FY2028 2,67 €
2,64 € – 2,69 €
4,20B 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-26 0,78 € 0,77 € -1,8%
2025-11-05 0,75 € 0,80 € +6,7%
2025-08-06 0,59 € 0,57 € -3,4%
2025-05-07 0,56 € 0,60 € +7,1%
2025-02-27 0,92 € 0,93 € +1,1%
2024-11-06 0,82 € 0,81 € -1,2%
2024-08-02 0,48 € 0,53 € +10,4%
2024-05-07 0,24 € 0,29 € +20,8%

Dividend History

7 yr streak

Yield

0,08%

Payout Ratio

-0,11%

Growth (3Y)

3,71%

Growth (5Y)

5,21%

Ex-Date Payment Date Amount Yield
Mar 02, 2026 Mar 24, 2026 0,29 € 9,40%
Nov 28, 2025 Dec 16, 2025 0,29 € 8,69%
Aug 29, 2025 Sep 16, 2025 0,29 € 4,83%
May 30, 2025 Jun 17, 2025 0,29 € 4,23%
Mar 07, 2025 Mar 25, 2025 0,29 € 4,03%
Nov 29, 2024 Dec 17, 2024 0,28 € 3,87%
Aug 30, 2024 Sep 17, 2024 0,28 € 3,78%
May 31, 2024 Jun 18, 2024 0,28 € 3,99%
Mar 07, 2024 Mar 26, 2024 0,28 € 3,69%
Nov 30, 2023 Dec 19, 2023 0,27 € 3,59%
Aug 31, 2023 Sep 19, 2023 0,27 € 3,08%
Jun 01, 2023 Jun 20, 2023 0,27 € 3,33%
Mar 09, 2023 Mar 28, 2023 0,27 € 2,90%
Dec 01, 2022 Dec 20, 2022 0,26 € 3,24%
Sep 01, 2022 Sep 20, 2022 0,26 € 2,77%
Jun 02, 2022 Jun 21, 2022 0,26 € 2,52%
Feb 25, 2022 Mar 17, 2022 0,26 € 2,75%
Dec 02, 2021 Dec 21, 2021 0,24 € 2,68%
Sep 02, 2021 Sep 21, 2021 0,24 € 2,28%
Jun 03, 2021 Jun 22, 2021 0,24 € 1,96%

Points Clés

Revenue grew 0,68% annually over 5 years — modest growth
Generating 145,10M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,43%
Capital efficient — spends only 2,20% of revenue on capex
ROIC of 3,73% — low return on invested capital
Dividends growing 5,21% annually over 5 years

Croissance

Revenue Growth (5Y)
0,68%
Revenue (1Y)-2,75%
Earnings (1Y)N/A
FCF Growth (3Y)-30,89%

Qualité

Return on Equity
-39,29%
ROIC3,73%
Net Margin-33,51%
Op. Margin8,07%

Sécurité

Debt / Equity
1,35
Current Ratio2,76
Interest Coverage2,11

Valorisation

P/E Ratio
-0,94
Forward P/E4,25
P/B Ratio0,45
EV/EBITDA13,90
Dividend Yield0,08%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -2,75% Revenue Growth (3Y) -4,42%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 0,68% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4,25B Net Income (TTM) -1,43B
ROE -39,29% ROA -16,70%
Gross Margin 35,14% Operating Margin 8,07%
Net Margin -33,51% Free Cash Flow (TTM) 145,10M
ROIC 3,73% FCF Growth (3Y) -30,89%
Safety
Debt / Equity 1,35 Current Ratio 2,76
Interest Coverage 2,11
Dividends
Dividend Yield 0,08% Payout Ratio -0,11%
Dividend Growth (3Y) 3,71% Dividend Growth (5Y) 5,21%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio -0,94 Forward P/E 4,25
P/B Ratio 0,45 P/S Ratio 0,31
PEG Ratio 0,00 Forward PEG N/A
EV/EBITDA 13,90 Fwd EV/EBITDA 21,22
Forward P/S 0,32 Fwd Earnings Yield 23,53%
FCF Yield 10,88%
Market Cap 1,33B Enterprise Value 4,77B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4,25B 4,37B 4,66B 4,45B 4,14B
Net Income -1,43B -171,80M -12,70M -140,60M -68,90M
EPS (Diluted) -10,29 -1,25 -0,09 -0,97 -0,98
Gross Profit 1,49B 1,54B 1,68B 1,46B 1,42B
Operating Income 343,30M 112,90M 151,90M 78,90M 410,40M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8,54B 9,65B 10,81B 11,02B 10,43B
Total Liabilities 5,60B 5,33B 6,04B 6,18B 5,27B
Shareholders' Equity 2,94B 4,32B 4,77B 4,84B 5,15B
Total Debt 3,97B 3,62B 4,07B 4,32B 3,69B
Cash & Equivalents 531,60M 558,80M 751,30M 600,70M 1,86B
Current Assets 2,80B 2,48B 2,83B 2,72B 3,86B
Current Liabilities 1,01B 1,04B 1,59B 1,11B 1,59B